pLV hUbC-dCas9 KRAB-T2A-GFP Citations (8)
Originally described in: Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector.Kabadi AM, Ousterout DG, Hilton IB, Gersbach CA Nucleic Acids Res. 2014 Aug 13. pii: gku749. PubMed Journal
Articles Citing pLV hUbC-dCas9 KRAB-T2A-GFP
| Articles |
|---|
| HiCAR is a robust and sensitive method to analyze open-chromatin-associated genome organization. Wei X, Xiang Y, Peters DT, Marius C, Sun T, Shan R, Ou J, Lin X, Yue F, Li W, Southerland KW, Diao Y. Mol Cell. 2022 Mar 17;82(6):1225-1238.e6. doi: 10.1016/j.molcel.2022.01.023. Epub 2022 Feb 22. PubMed |
| A Therapeutically Targetable NOTCH1-SIRT1-KAT7 Axis in T-cell Leukemia. Lancho O, Singh A, da Silva-Diz V, Aleksandrova M, Khatun J, Tottone L, Nunes PR, Luo S, Zhao C, Zheng H, Chiles E, Zuo Z, Rocha PP, Su X, Khiabanian H, Herranz D. Blood Cancer Discov. 2023 Jan 6;4(1):12-33. doi: 10.1158/2643-3230.BCD-22-0098. PubMed |
| E2F1 combined with LINC01004 super-enhancer to promote hepatocellular carcinoma cell proliferation and metastasis. Li J, Wang J, Wang Y, Zhao X, Su T. Clin Epigenetics. 2023 Jan 31;15(1):17. doi: 10.1186/s13148-023-01428-6. PubMed |
| Activation of the imprinted Prader-Willi Syndrome locus by CRISPR-based epigenome editing. Rohm D, Black JB, McCutcheon SR, Barrera A, Morone DJ, Nuttle X, de Esch CE, Tai DJC, Talkowski ME, Iglesias N, Gersbach CA. bioRxiv [Preprint]. 2024 Mar 4:2024.03.03.583177. doi: 10.1101/2024.03.03.583177. PubMed |
Activation of the imprinted Prader-Willi syndrome locus by CRISPR-based epigenome editing.
Rohm D, Black JB, McCutcheon SR, Barrera A, Berry SS, Morone DJ, Nuttle X, de Esch CE, Tai DJC, Talkowski ME, Iglesias N, Gersbach CA.
Cell Genom. 2025 Feb 12;5(2):100770. doi: 10.1016/j.xgen.2025.100770.
PubMed
Associated Plasmids |
| The histone modifier KAT2A presents a selective target in a subset of well-differentiated microsatellite-stable colorectal cancers. Kufrin V, Seiler A, Brilloff S, Rothfuss H, Kuchler S, Schafer S, Rahimian E, Baumgarten J, Ding L, Buchholz F, Ball CR, Bornhauser M, Glimm H, Bill M, Wurm AA. Cell Death Differ. 2025 Jul;32(7):1259-1272. doi: 10.1038/s41418-025-01479-7. Epub 2025 Mar 27. PubMed |
| Investigation of lncRNA expression in newly diagnosed multiple myeloma reveals a LINC01432-CELF2 axis as an inhibitor of apoptosis. Mishra R, Thunuguntla P, Duraiyan D, Perkin A, Bagwill K, Gonzales S, Sizemore C, Brizuela V, King J, Daly S, Chang YJ, Abebe M, Rajana Y, Wichmann K, Enyan C, Rangineni S, Fiala M, Fortier J, Jayasinghe R, Schroeder M, Ding L, Vij R, DiPersio J, Silva-Fisher J. Oncogenesis. 2025 Oct 6;14(1):36. doi: 10.1038/s41389-025-00579-w. PubMed |
| Cell cycle regulator MYBL2 is a distinct vulnerability in acute myeloid leukemia. Kuchler S, Brilloff S, Schafer S, Rahimian E, Kufrin V, Peri SS, Musa J, Grunewald TGP, Schewe DM, Ball CR, Bornhauser M, Glimm H, Bill M, Wurm AA. Cell Death Discov. 2025 Oct 20;11(1):470. doi: 10.1038/s41420-025-02810-4. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.